Historical Stock Price
CLSN historical stock prices picture
CLSN (CLSN) has the following price history information. Looking back at CLSN historical stock prices for the last five trading days, on September 14, 2022, CLSN opened at $2.10, traded as high as $2.13 and as low as $2.02, and closed at $2.07. Trading volume was a total of 20.70K shares. On September 15, 2022, CLSN opened at $2.05, traded as high as $2.29 and as low as $2.02, and closed at $2.08. Trading volume was a total of 33.20K shares. On September 16, 2022, CLSN opened at $2.03, traded as high as $2.11 and as low as $2.02, and closed at $2.04. Trading volume was a total of 16.90K shares. On September 19, 2022, CLSN opened at $2.01, traded as high as $2.02 and as low as $1.93, and closed at $1.96. Trading volume was a total of 45.90K shares. On September 20, 2022, CLSN opened at $1.96, traded as high as $2.00 and as low as $1.93, and closed at $1.96. Trading volume was a total of 68.00K shares.

CLSN Historical Stock Prices By Date:

CLSN historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into CLSN shares, starting with a $10,000 purchase of CLSN, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 03/31/2014
End date: 09/20/2022
Start price/share: $707.70
End price/share: $1.96
Dividends collected/share: $0.00
Total return: -99.72%
Average Annual Total Return: -50.07%
Starting investment: $10,000.00
Ending investment: $27.69
Years: 8.48
Date Open High Low Close Volume
09/14/2022 $2.10 $2.13 $2.02 $2.07 20.70K
09/15/2022 $2.05 $2.29 $2.02 $2.08 33.20K
09/16/2022 $2.03 $2.11 $2.02 $2.04 16.90K
09/19/2022 $2.01 $2.02 $1.93 $1.96 45.90K
09/20/2022 $1.96 $2.00 $1.93 $1.96 68.00K
Celsion is a clinical stage biotechnology company. Co.'s product pipeline includes GEN-1, a DNA-based immunotherapy for the treatment of ovarian cancer. ThermoDox®, Co.'s proprietary heat-activated liposomal encapsulation of doxorubicin, is under investigator-sponsored development for several cancer indications, which is being managed though Co.'s wholly owned subsidiary, Celsion GmbH. Additionally, Co. has two feasibility stage platform technologies for the development of nucleic acid-based immunotherapies and vaccines and other anti-cancer DNA or RNA therapies. Both are synthetic, non-viral vectors with demonstrated capability in nucleic acid cellular transfection.
Date Close
09/14/2022$2.07
09/15/2022$2.08
09/16/2022$2.04
09/19/2022$1.96
09/20/2022$1.96
CLSN is categorized under the Healthcare sector; below are some other companies in the same sector:

CLVS Historical Stock Prices
CMD Historical Stock Prices
CMN Historical Stock Prices
CMRX Historical Stock Prices
CNAT Historical Stock Prices
CNC Historical Stock Prices
CNCE Historical Stock Prices
CNDO Historical Stock Prices
CNJ Historical Stock Prices
CNMD Historical Stock Prices

Also explore: CLSN shares outstanding history

Email EnvelopeFree CLSN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


CLSN Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.